Literature DB >> 22539400

Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies.

P Danhier1, G De Preter, S Boutry, I Mahieu, P Leveque, J Magat, V Haufroid, P Sonveaux, C Bouzin, O Feron, R N Muller, B F Jordan, B Gallez.   

Abstract

MRI cell tracking is a promising technique to track various cell types (stem cells, tumor cells, etc.) in living animals. Usually, cells are incubated with iron oxides (T(2) contrast agent) in order to take up the particles before being injected in vivo. Iron oxide quantification is important in such studies for validating the labeling protocols and assessing the dilution of the particles with cell proliferation. We here propose to implement electron paramagnetic resonance (EPR) as a very sensitive method to quantify iron oxide concentration in cells. Iron oxide particles exhibit a unique EPR spectrum, which directly reflects the number of particles in a sample. In order to compare EPR with existing methods (Perls's Prussian blue reaction, ICP-MS and fluorimetry), we labeled tumor cells (melanoma and renal adenocarcinoma cell lines) and fibroblasts with fluorescent iron oxide particles, and determined the limits of detection of the different techniques. We show that EPR is a very sensitive technique and is specific for iron oxide quantification as measurements are not affected by endogenous iron. As a consequence, EPR is well adapted to perform ex vivo analysis of tissues after cell tracking experiments in order to confirm MRI results.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539400     DOI: 10.1002/cmmi.497

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  5 in total

1.  Magnetic Characterization of Iron Oxide Nanoparticles for Biomedical Applications.

Authors:  Lorena Maldonado-Camargo; Mythreyi Unni; Carlos Rinaldi
Journal:  Methods Mol Biol       Date:  2017

2.  Rapid spectrophotometric technique for quantifying iron in cells labeled with superparamagnetic iron oxide nanoparticles: potential translation to the clinic.

Authors:  Esmaeel R Dadashzadeh; Matthew Hobson; L Henry Bryant; Dana D Dean; Joseph A Frank
Journal:  Contrast Media Mol Imaging       Date:  2013 Jan-Feb       Impact factor: 3.161

3.  Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies.

Authors:  Pierre Danhier; Gladys Deumer; Nicolas Joudiou; Caroline Bouzin; Philippe Levêque; Vincent Haufroid; Bénédicte F Jordan; Olivier Feron; Pierre Sonveaux; Bernard Gallez
Journal:  Oncotarget       Date:  2017-06-13

4.  Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma.

Authors:  Lakshmi Pallavi Ganipineni; Bernard Ucakar; Nicolas Joudiou; John Bianco; Pierre Danhier; Mengnan Zhao; Chiara Bastiancich; Bernard Gallez; Fabienne Danhier; Véronique Préat
Journal:  Int J Nanomedicine       Date:  2018-08-08

Review 5.  Iron Oxide as an MRI Contrast Agent for Cell Tracking.

Authors:  Daniel J Korchinski; May Taha; Runze Yang; Nabeela Nathoo; Jeff F Dunn
Journal:  Magn Reson Insights       Date:  2015-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.